Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Assessment of programmed cell death-ligand 1 (PD-L1) expression by immunohistochemistry (IHC) is the definite diagnostic test to guide treatment for patients with advanced-stage non-small cell lung cancer. Intratumoral heterogeneity and discrepancy of PD-L1 expression between primary and metastatic...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Immunother Cancer
Asıl Yazarlar: Moutafi, Myrto K, Tao, Weiwei, Huang, Richard, Haberberger, James, Alexander, Brian, Ramkissoon, Shakti, Ross, Jeffrey S, Syrigos, Konstantinos, Wei, Wei, Pusztai, Lajos, Rimm, David L, Vathiotis, Ioannis A
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMJ Publishing Group 2021
Konular:
Immunotherapy Biomarkers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039214/
https://ncbi.nlm.nih.gov/pubmed/33833050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-002230
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller